Efficient and Precise: The Evolution of Aptamer Screening

Aptamers are functional nucleic acids selected via in vitro screening, with broad potential in biomedical applications. Screening methods continue to evolve, allowing tailored selection based on target properties.

Screening Method Principles

Traditional SELEX enriches aptamers through repeated binding–elution–amplification cycles, typically using immobilized proteins and competitive elution. Capillary Electrophoresis SELEX separates bound and free nucleic acids via mobility differences in free solution, avoiding immobilization and improving efficiency. Cell-SELEX employs living cells under near-physiological conditions, ideal for membrane protein targets. Microfluidic SELEX integrates screening steps on-chip for high-throughput automation.

Performance and Selection Guidelines

Traditional SELEX (8–15 cycles) yields pM–nM affinity aptamers against soluble proteins, aided by negative selection. Capillary Electrophoresis SELEX shortens screening to 1–4 rounds, achieving high specificity for soluble targets. Cell-SELEX (10–20 rounds) targets cell-surface markers with counter-selection for specificity. Microfluidic SELEX platforms complete screening in 3–8 rounds with broad target applicability.

For soluble proteins, traditional SELEX remains reliable. For membrane proteins requiring native conformation, Cell-SELEX is advantageous. When rapid screening is needed, Capillary Electrophoresis SELEX or Microfluidic SELEX are preferable. For complex targets like pathogens, integrated strategies combining different screening approaches improve specificity.

Future Directions

Emerging trends include combining computational analysis with experimental screening to guide selection, hybrid methods such as Capillary Electrophoresis SELEX pre-enrichment followed by cellular validation, and automated platforms that integrate SELEX steps for improved reproducibility.

Read More

Alpha Lifetech leverages extensive SELEX expertise to deliver comprehensive Aptamer Development Services, including screening, synthesis, and validation of high-affinity, high-stability Nucleic Acid Aptamers. Moerover, we can also provide different Targeting Ligands services like Peptide Library Screening Services.

发表回复

您的邮箱地址不会被公开。 必填项已用 * 标注